Only one in five Medicaid enrollees diagnosed with hepatitis C virus started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.
Board Governance: Navigating Emerging Technologies and More in a Complex World, a new Cornell Tech immersion program, is set to prepare corporate board members for fast-paced evolutions driving the future of commerce.
During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.”
The initiative is designed to improve standards of online privacy, safety and security, and to establish New York City as the epicenter of cybersecurity research.
Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43%, from 5.3% to 7.6% a year.
Using a deep learning computer model and dashcam images from New York City rideshare drivers, Cornell Tech researchers were able to see which neighborhoods had the highest numbers of New York Police Department marked vehicles.
Weill Cornell Medicine and Columbia University have been awarded a five-year, $9.8 million grant from the National Cancer Institute to help combat cancer disparities fueled by persistent poverty.
An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer.
Faculty in Cornell’s Action Research Collaborative (ARC) joined New York City and State policymakers and community members for ARC’s second symposium on June 22. The annual symposium is an opportunity for researchers, policymakers and community stakeholders to share their knowledge and advance equity in areas like nutrition and health, housing and social services, and youth development.
